Quick Answer
DEXCOM INC reported Diluted EPS of $2.09 per share for fiscal year 2025.
DEXCOM INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.09 | +47.2% |
| 2024 | $1.42 | +9.2% |
| 2023 | $1.30 | +58.5% |
| 2022 | $0.82 | +54.7% |
| 2021 | $0.53 | -60.2% |
| 2020 | $1.33 | +20.9% |
| 2019 | $1.10 | +176.4% |
| 2018 | -$1.44 | -148.3% |
| 2017 | -$0.58 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.70 | +105.9% | +55.6% |
| June 30, 2025 | $0.45 | +28.6% | +66.7% |
| March 31, 2025 | $0.27 | -25.0% | -20.6% |
| September 30, 2024 | $0.34 | +17.2% | -2.9% |
| June 30, 2024 | $0.35 | +25.0% | -2.8% |
| March 31, 2024 | $0.36 | +200.0% | +24.1% |
| September 30, 2023 | $0.29 | +20.8% | +3.6% |
| June 30, 2023 | $0.28 | +133.3% | +133.3% |
- DEXCOM INC showed an increase of +47.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2017–2025 period, DEXCOM INC’s diluted eps has grown by 460.3% (from $0.58 per share (loss) to $2.09 per share).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: